Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Feasibility Study of a New Immunoglobulin E (IgE) Assay Method — Stella

Home/Allergy and Immunology/Feasibility Study of a New Immunoglobulin E (IgE) Assay Method

View on ClinicalTrials.gov

Recruiting

Back to Allergy and Immunology trials

Feasibility Study of a New Immunoglobulin E (IgE) Assay Method

Trial locations(2 sites)

France

University Hospital, Toulouse

Larrey hospital, Toulouse

Key details

Sponsor

University Hospital, Toulouse

Enrollment target

~1,376 participants

Started

April 2021

Primary completion

April 2026

Age range

6 Months – 99 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.